Page last updated: 2024-08-25

bendamustine hydrochloride and Carcinoma, Non-Small Cell Lung

bendamustine hydrochloride has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hong, SH; Kang, JH; Kim, YS; Kwak, YK; Lee, SW; Sung, S	1
Chinnaiyan, P; Neuger, A; Pan, E; Smith, P; Yu, D; Yu, HH; Zhao, X	1
Fischer, JR; Heider, A; Koch, JA; Köster, W; Niederle, N; Stahl, M; Stamatis, G; Wilke, H	1
Gatzemeier, U; Haering, B; Kaukel, E; Koschel, G; Reck, M; von Pawel, J	1

Trials

3 trial(s) available for bendamustine hydrochloride and Carcinoma, Non-Small Cell Lung

Article	Year
Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors. Journal of neuro-oncology, 2014, Volume: 119, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Survival Analysis; Treatment Outcome	2014
Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carboplatin; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Patient Selection; Probability; Risk Assessment	2007
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study]. Pneumologie (Stuttgart, Germany), 1998, Volume: 52, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Palliative Care; Survival Rate; Treatment Outcome	1998

Other Studies

1 other study(ies) available for bendamustine hydrochloride and Carcinoma, Non-Small Cell Lung

Article	Year
Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer. Journal of neuro-oncology, 2018, Volume: 139, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; ErbB Receptors; Female; Humans; Incidence; Male; Middle Aged; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases	2018

Article

Year

Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer.

Journal of neuro-oncology, 2018, Volume: 139, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; ErbB Receptors; Female; Humans; Incidence; Male; Middle Aged; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases

2018